Zobrazeno 1 - 10
of 212
pro vyhledávání: '"Jm, Sloan"'
Publikováno v:
Poster presentations.
Background We redesigned a Renal Supportive Care (RSC) service in 2012 for patients with chronic kidney disease (CKD) managed without dialysis. We audited the service to evaluate impact on symptoms and care pathways. Methods The RSC service allows co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee8fe6026758aa2bfaedcb16c27fcdd1
https://doi.org/10.1136/bmjspcare-2018-aspabstracts.182
https://doi.org/10.1136/bmjspcare-2018-aspabstracts.182
Autor:
Drew J Winston, Kathleen M Mullane, Oliver A Cornely, Michael J Boeckh, Janice Wes Brown, Steven A Pergam, Igoris Trociukas, Pavel Žák, Michael D Craig, Genovefa A Papanicolaou, Juan D Velez, Jens Panse, Kimberly Hurtado, Doreen A Fernsler, Jon E Stek, Lei Pang, Shu-Chih Su, Yanli Zhao, Ivan S F Chan, Susan S Kaplan, Janie Parrino, Ingi Lee, Zoran Popmihajlov, Paula W Annunziato, Ann Arvin, AC Basso, P Bonvehi, S Cerana, MO Dictar, P Campbell, G Playford, J Sasadeusz, J Maertens, X Poire, D Sellesag, R Schots, K Theunissen, E Willems, RS Alves, JFC Camargo, NS Castro, L Maria Fogliatto, O Rodrigo, F Courture, A McGeer, M Miller, JF Combariza, CL Sossa, JD Velez, D Nemet, S Ostojic Kolonic, L Jebavy, J Mayer, J Novak, D Pohlreich, B Maldonado, T Gastinne, L Karlin, O Launay, OA Cornely, HA Duerk, M Haenel, W Heinz, M Kaufmann, J Panse, D Teschner, M Verbeek, G Wulf, F Aviv, S Grisariu, A Nagler, M Yeshurun, A Bosi, P Corradini, G Martinelli, F Onida, A Rambaldi, A Velardi, I Trociukas, AD Gomez, MJ Wondergem, PF Ypma, E Fanilla, MDC Moreno Larrea, MM Abecasis, RB Ferreira, C Geraldes, J Castro, BV Afanasyev, IV Kruchkova, AY Zaritskiy, JW Cheong, SJ Kim, DG Lee, SS Yoon, B Aguado Bueno, I Jarque Ramos, C Solano Vercet, H Cherif, P Ljungman, K Vaht, G Cook, E Kanfer, DW Milligan, A Parker, L Akard, C Bachier, ED Ball, FR Betts, I Braunschweig, JM Brown, MP Carroll, PH Chandrasekar, R Collins, B Cooper, M Craig, N D'Cunha, ML Donato, J Essell, P Flomenberg, A Freifeld, C Freytes, MJ Guarino, MC Hall, JW Heimenz, KP High, LM Isola, L Kaminer, LM Klein, N Janakiraman, K Kane, K Komanduri, OI Krijanovski, SJ Lawrence, JF Leis, M Lill, WL Longo, JP Lynch, BI Mattar, J Mehta, KM Mullane, S Nathan, GA Papanicolaou, SA Pergam, V Roy, W Rybka, H Safah, D Saltzman, GM Segal, GB Selby, MW Schuster, S Shoham, JM Sloan, LM Strasfeld, M Styler, K Sullivan, W Tse, EA Vance, DJ Winston, S Yanovich
Summary Background Recipients of autologous haemopoietic stem-cell transplants (auto-HSCT) have an increased risk of herpes zoster and herpes zoster-related complications. The aim of this study was to establish the efficacy and safety of an inactivat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c88581fe01ba74293864278cb36827e0
http://hdl.handle.net/11391/1448321
http://hdl.handle.net/11391/1448321
Autor:
Gm, Spence, An, Graham, Mulholland K, Ian McAllister, Jm, Sloan, Ma, Armstrong, Fc, Campbell, Ja, Mcguigan
Publikováno v:
Europe PubMed Central
In patients with cancer circulating vascular endothelial growth factor (VEGF) may be tumor-derived and have prognostic significance. Activated platelets may also be a source of VEGF, releasing it in serum formation. Debate exists as to whether serum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5707ce737b3512f6174da302c553d015
https://pubmed.ncbi.nlm.nih.gov/12113578
https://pubmed.ncbi.nlm.nih.gov/12113578
Autor:
Abdallah M; Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts, United States., Arters F; Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, United States., Patel J; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Edwards CV; Boston Medical Center, Boston, Massachusetts, United States., Lerner A; Boston University School of Medicine, Boston, Massachusetts, United States., Petrocca F; Boston University School of Medicine, Boston, Massachusetts, United States., Dockerty M; Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts, United States., Fuller B; Section of Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA, United States., Godfrey A; Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts, United States., Staron A; Boston Medical Center, Boston, Massachusetts, United States., Sanchorawala V; Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts, United States., Sloan JM; Boston University, Boston, Massachusetts, United States., Bertrand KA; Boston University, Boston, Massachusetts, United States., Szalat RE; Boston University School of Medicine, Boston, Massachusetts, United States.
Publikováno v:
Blood advances [Blood Adv] 2024 Sep 30. Date of Electronic Publication: 2024 Sep 30.
Defying the Odds: 30 Years in AL Amyloidosis Research, Recent Barriers to Clinical Trial Enrollment.
Autor:
Sanchorawala V; Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts, United States., Barroso B; Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts, United States., Shelton AC; Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts, United States., Goetz E; Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts, United States., Mendelson L; Boston University School of Medicine, boston, Massachusetts, United States., Joshi T; Boston University School of Medicine, Boston, Massachusetts, United States., Burke NJ; Boston University School of Medicine, Boston, Massachusetts, United States., Sloan JM; Boston University, Boston, Massachusetts, United States., Staron A; Boston Medical Center, Boston, Massachusetts, United States.
Publikováno v:
Blood advances [Blood Adv] 2024 Sep 18. Date of Electronic Publication: 2024 Sep 18.
Autor:
Hibbs SP; Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom., Aiken L; Barts Health NHS Trust, London, United Kingdom., Vora K; Department of Medicine, Massachusetts General Hospital, Boston., Mowete C; Barts Health NHS Trust, London, United Kingdom.; Blizard Institute, Queen Mary University of London, London, United Kingdom.; NHS Blood and Transplant, London, United Kingdom., Merz LE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Bioethics, Harvard Medical School, Boston, Massachusetts., Apea V; Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.; Barts Health NHS Trust, London, United Kingdom., Sloan JM; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts., Lathan CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Bioethics, Harvard Medical School, Boston, Massachusetts., Abel GA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Bioethics, Harvard Medical School, Boston, Massachusetts., Hantel A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Bioethics, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
JAMA network open [JAMA Netw Open] 2024 Sep 03; Vol. 7 (9), pp. e2432475. Date of Electronic Publication: 2024 Sep 03.
Autor:
Zheng R; UMass Chan Medical School, UMass Medical Center, Department of Medicine, Division of Hematology-Oncology, Worcester, MA, USA., Solomon A; Eastern Vascular Associates, Denville, NJ, USA., DiLorenzo M; New York University Grossman School of Medicine, Department of Medicine, Division of Infectious Diseases and Immunology, New York, NY, USA., Rajendran I; University of Arizona, College of Medicine, Department of Medicine, Division of Cardiology, Tucson, AZ, USA., Park J; Brigham and Women's Hospital, Department of Medicine, Boston, MA, USA., Dhongade V; Brigham and Women's Hospital, Department of Neurology, Boston, MA, USA., Garcia MA; Valley Medical Center Pulmonary & Sleep Disorder Clinic, Covington, WA, USA., Eberhardt RT; Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Department of Medicine, Section of Cardiovascular Medicine, Boston, MA, USA., Sloan JM; Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Department of Medicine, Section of Hematology & Medical Oncology, Boston, MA, USA., Weinberg J; Boston University School of Public Health, Department of Biostatistics, Boston, MA, USA., Klings ES; Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Department of Medicine, The Pulmonary Center, Boston, MA, USA.
Publikováno v:
Advances in hematology [Adv Hematol] 2024 Mar 11; Vol. 2024, pp. 8838308. Date of Electronic Publication: 2024 Mar 11 (Print Publication: 2024).
Autor:
Sarosiek S; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, Massachusetts., Lee MH; Section of Hematology and Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts., Doros G; Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts., Edwards CV; Section of Hematology and Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts; Stem Cell Transplant Program of Section of Hematology and Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts; Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts., Quillen K; Department of Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Brauneis D; Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts., Shelton AC; Section of Hematology and Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts., Sanchorawala V; Section of Hematology and Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts; Stem Cell Transplant Program of Section of Hematology and Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts; Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts., Sloan JM; Section of Hematology and Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts; Stem Cell Transplant Program of Section of Hematology and Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts; Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts. Electronic address: mark.sloan@bmc.org.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2023 Nov; Vol. 29 (11), pp. 695.e1-695.e7. Date of Electronic Publication: 2023 Aug 20.
Autor:
Freydman J; Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA., Staron A; Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA., Hughes D; Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA., Sloan JM; Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA.
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2023 Sep; Vol. 29 (6), pp. 1489-1493. Date of Electronic Publication: 2023 May 08.
Autor:
Halpin M; Boston University Chobanian & Avedisian School of Medicine Department of Medicine Section of Hematology and Oncology., Lerner A; Boston University Chobanian & Avedisian School of Medicine Department of Medicine Section of Hematology and Oncology., Sagar M; Boston University Chobanian & Avedisian School of Medicine Department of Medicine Section of Infectious Disease., Govender P; Boston University Chobanian & Avedisian School of Medicine Department of Medicine Section of Pulmonology., Shah B; Boston University Chobanian & Avedisian School of Medicine Department of Medicine Section of Hematology and Oncology., Weinberg J; Boston University School of Public Health., Sarosiek S; Dana Farber Cancer Institute., Sloan JM; Boston University Chobanian & Avedisian School of Medicine Department of Medicine Section of Hematology and Oncology.
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2023 Jun 06. Date of Electronic Publication: 2023 Jun 06.